Search results for: 'efficient energy control'

03 Jul 2018  |  Asia Pacific  |  Market Research

Asia-Pacific Integrated Facilities Management Market, Forecast to 2022

Cost Efficiency, Standardization, Long-term Partnerships and Technology Adoption are Key Trends

Infographics

×

Key Issues Addressed

The Asia-Pacific integrated facilities management (IFM) market is witnessing stable growth, primarily supported by rapid growth and development of facilities management (FM) in developing markets, but offset by lower growth in mature markets. High construction activity and booming end-user sectors, coupled with the growing outsourcing culture and a...

In 2026, the construction management sector is accelerating its digital transformation, with agentic AI systems emerging as a cornerstone for automating comprehensive project workflows and overcoming chronic issues such as labor shortages, escalating costs, and persistent delays. These intelligent agents, powered by generative capabilities, enable ...

This study provides information on the global belt and chain drives market. It lists the major trends and the prevailing scenario across all regions and discusses the major drivers and challenges that will impact the market in the future. While improvements in belt design and the use of lubrication for chains has improved the life of these products...

Frost & Sullivan defines digital health as data application for healthcare delivery using computational and telecommunication technologies to support business process workflow, clinical workflow, and patient data management. Digital health aims to achieve better patient outcomes while improving efficiency and containing costs through provider and p...

14 Aug 2015  |  Global  |  Market Research

Global Low-voltage Switchgear Market

The Modernisation of Public Infrastructure and the Adoption of Renewable Energy Systems Will Revitalize Market Growth

Infographics

×

The low-voltage (LV) switchgear market has been sluggish in recent years but is poised to record accelerated growth over the next few years. LV components, such as miniature circuit breakers (MCBs) and residual current circuit breakers (RCCBs), contributed most of the market share in 2014, which was primarily due to the demand from the residential ...

This research service is a comprehensive study of the transmission equipment (69kV and above) market growth over the next ten years (from 2021 to 2030). It includes transmission substation, power transformers, transmission cable length, and circuit breakers. The report covers North America, Europe, Asia-Pacific, Middle East, Latin America, and Afri...

14 Jun 2022  |  Global  |  Market Research

Global High-voltage (HV) Gas-insulated Switchgear (GIS) Growth Opportunities

Net-zero Energy Transition Commitments and the Increased Spend on Transmission Networks will Fuel Market Growth

Infographics

×

Key Issues Addressed

This Frost & Sullivan research service offers a comprehensive analysis of the high-voltage (HV) gas-insulated switchgear (GIS) (including SF6-insulated and alternative gas-insulated equipment rated above 72.5kV) market from 2022 to 2030. The study presents a market revenue forecast based on region (North America; Europe; Asia-Pacific (further segme...

This air compressors fact book provides information on the key trends affecting the industrial air compressors market. Markets faced significant constraints as COVID-19 disrupted the value chain and restricted the movement of personnel. While most companies bounced back strongly in 2021 with increased orders, growth has not been even. Compressor ma...

01 Mar 2024  |  North America  |  Market Research

Global Orphan Drug Growth Opportunities

Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions

Infographics

×

In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...